J&J spends $3.4 billion in cash for Auris Health’s lung cancer diagnostics and surgical robots

J&J spends $3.4 billion in cash for Auris Health’s lung cancer diagnostics and surgical robots
Johnson & Johnson’s robotic surgery and medical device division, Ethicon, is dropping $3.4 billion in cash to pick up Auris Health, a developer of robotic diagnostics and surgical devices initially focused on detecting and treating lung cancer. The healthcare giant said an additional $2.35 billion in payouts may be possible ... read more
Source- Techcrunch.comPublished on 2019-02-13By Jonathan Shieber
2 months ago
Share this content